Evidence Central | Azathioprine or 6-mercaptopurine for maintaining remission in Crohn's disease

Download the app!

INSTALL

Azathioprine or 6-mercaptopurine for maintaining remission in Crohn's disease

47 results

1 - 47

Azathioprine or 6-mercaptopurine for maintaining remission in Crohn's disease
- Evidence Summaries
- References
Azathioprine or 6‐mercaptopurine for maintenance of remission in Crohn's disease
- Abstract
Azathioprine or 6-mercaptopurine for inducing remission of Crohn's disease
- Evidence Summaries
Azathioprine or 6‐mercaptopurine for induction of remission in Crohn's disease
- Abstract
Azathioprine and 6‐mercaptopurine for maintenance of surgically‐induced remission in Crohn's disease
- Abstract
Adalimumab for maintenance of remission in Crohn's disease
- Abstract
- Reviewer's Conclusions
Oral 5‐aminosalicylic acid for maintenance of surgically‐induced remission in Crohn's disease
- Abstract
Oral 5-aminosalicylic acid for maintenance of surgically-induced remission in Crohn's disease
- Evidence Summaries
Enteral nutrition for maintenance of remission in Crohn's disease
- Abstract
- Reviewer's Conclusions
Methotrexate for maintenance of remission in Crohn's disease
- Abstract
Infliximab for maintenance of medically‐induced remission in Crohn's disease
- Abstract
Thalidomide and thalidomide analogues for maintenance of remission in Crohn's disease
- Abstract
Tumor necrosis factor‐alpha antibody for maintenance of remission in Crohn's disease
- Abstract
Anti‐tuberculous therapy for maintenance of remission in Crohn's disease
- Abstract
- Reviewer's Conclusions
Budesonide for maintenance of remission in Crohn's disease
- Abstract
Vedolizumab for induction and maintenance of remission in Crohn's disease
- Abstract
- Reviewer's Conclusions
Methotrexate for maintenance of remission in ulcerative colitis
- Abstract
Oral 5‐aminosalicylic acid for maintenance of medically‐induced remission in Crohn's disease
- Abstract
Interventions for maintenance of surgically induced remission in Crohn’s disease: a network meta‐analysis
- Abstract
Omega 3 fatty acids (fish oil) for maintenance of remission in Crohn's disease
- Abstract
Anti‐IL‐12/23p40 antibodies for maintenance of remission in Crohn's disease
- Abstract
Glutamine for induction of remission in Crohn's disease
- Abstract
Infliximab for maintenance of medically induced remission in Crohn's disease
- Evidence Summaries
Antibiotics for induction and maintenance of remission in Crohn's disease
- Abstract
- Reviewer's Conclusions
Corticosteroids for maintenance of remission in Crohn's disease
- Abstract
Certolizumab pegol for maintenance of medically induced remission in Crohn’s disease
- Abstract
Oral Janus kinase inhibitors for maintenance of remission in ulcerative colitis
- Abstract
Interventions for the management of abdominal pain in Crohn's disease and inflammatory bowel disease
- Reviewer's Conclusions
1 - 47 of 47 records

Log in to Evidence Central

Contact Support

If you need further assistance, please contact Support.

unboundmedicine.com/support
support@unboundmedicine.com
610-627-9090(Monday - Friday, 9 AM - 5 PM EST.)

Password reset sent

Username sent

A Evidence Central subscription is required to

Already have an account?